Ensysce Biosciences Announces Positive End of Phase 2 Meeting with FDA for PF614 to Treat Severe Pain
~ PF614 Phase 3 Program Expected to Begin Enrollment in Mid-2024 ~SAN DIEGO, CA / ACCESSWIRE / January 31, 2024
Home » Press Releases » Page 72
~ PF614 Phase 3 Program Expected to Begin Enrollment in Mid-2024 ~SAN DIEGO, CA / ACCESSWIRE / January 31, 2024
FORT PIERCE, FL / ACCESSWIRE / January 31, 2024 / Forza X1, Inc. (Nasdaq:FRZA) (“Forza,” the “Company”), a developer of
GREENBRAE, CA / ACCESSWIRE / January 31, 2024 / Marin Fertility Center, a renowned facility specializing in reproductive health, announces
CEO Joe Ward and VP of Engineering Blake Fox will share perspectives on enterprise uses and impactsSAN DIEGO, CA /
Employers working with at least one independent contractor must ensure compliance to avoid penalties.FAYETTEVILLE, AR and DALLAS, TX / ACCESSWIRE
MONTREAL, QC / ACCESSWIRE / January 31, 2024 / Valsoft Corporation Inc. (“Valsoft”), a Canadian company specializing in the acquisition
MONTRÉAL, QC / ACCESSWIRE / le 31 janvier 2024 / Valsoft Corporation inc. (« Valsoft »), société canadienne spécialisée dans l’acquisition et
KUALA LUMPUR, MALAYSIA / ACCESSWIRE / January 31, 2024 / Gaining an advantage might be crucial in the rapidly evolving
Libyan Newswire brings you the latest news and updates, covering advancements, innovations, and breakthroughs in various tech sectors.